Literature DB >> 7055590

Lipid composition of tracheobronchial secretions from normal individuals and patients with cystic fibrosis.

A Slomiany, V L Murty, M Aono, C E Snyder, A Herp, B L Slomiany.   

Abstract

The lipid composition of tracheobronchial secretions from normal individuals and patients with cystic fibrosis was investigated. Lipids were extracted from he dialyzed and lyophilized samples, and fractionated on silicic acid columns into neutral lipids, glycolipids and phospholipids. The lipids contained each fraction were separated into individual components by thin-layer chromatography and quantified. The secretions of patients with cystic fibrosis and were found to contain about 30% more lipids than that of normal individuals and exhibited elevated levels of cholesterol, phospholipids and glycosphingolipids. The level of free fatty acids and glyceroglucolipids was higher in the normal secretions. The phospholipids of cystic fibrosis secretions exhibited higher content of sphingomyelin and phosphatidylserine, while the normal samples contained more lysophosphatidylcholine. The glycosphingolipids of both types of samples consisted mainly of glucosyl- and lactosylceramides. The major glyceroglucolipid of the normal tracheobronchial secretions was tetraglucosyl glyceroglucolipid, whereas hexa-and octaglucosyl glyceroglucolipids were the predominant compounds of the cystic fibrosis secretions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7055590     DOI: 10.1016/0005-2760(82)90196-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Restoration of mucociliary transport in the fluid-depleted trachea by surface-active instillates.

Authors:  Stephen T Ballard; James C Parker; Charles R Hamm
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-15       Impact factor: 6.914

2.  Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repair.

Authors:  Yutaka Itokazu; Richard E Pagano; Andreas S Schroeder; Scott M O'Grady; Andrew H Limper; David L Marks
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-05       Impact factor: 4.249

Review 3.  Structure, biosynthesis, and function of salivary mucins.

Authors:  A M Wu; G Csako; A Herp
Journal:  Mol Cell Biochem       Date:  1994-08-17       Impact factor: 3.396

4.  Membrane-targeted synergistic activity of docosahexaenoic acid and lysozyme against Pseudomonas aeruginosa.

Authors:  Jose G Martinez; Michael Waldon; Qiyu Huang; Sandra Alvarez; Ami Oren; Natalie Sandoval; Ming Du; Feimeng Zhou; Alexandra Zenz; Karl Lohner; Robert Desharnais; Edith Porter
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

5.  Synthetic tracheal mucus with native rheological and surface tension properties.

Authors:  R Hamed; J Fiegel
Journal:  J Biomed Mater Res A       Date:  2013-06-29       Impact factor: 4.396

Review 6.  Engineering the Mucus Barrier.

Authors:  T L Carlson; J Y Lock; R L Carrier
Journal:  Annu Rev Biomed Eng       Date:  2018-06-04       Impact factor: 9.590

7.  Pathogenesis of corneal infection: binding of Pseudomonas aeruginosa to specific phospholipids.

Authors:  N Panjwani; Z Zhao; M B Raizman; F Jungalwala
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

Review 8.  The bidirectional relationship between CFTR and lipids.

Authors:  Kirsten A Cottrill; Carlos M Farinha; Nael A McCarty
Journal:  Commun Biol       Date:  2020-04-20

9.  Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients.

Authors:  Daniel C Ma; Alexander J Yoon; Kym F Faull; Robert Desharnais; Edith T Zemanick; Edith Porter
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

Review 10.  Proteomics and Metabolomics for Cystic Fibrosis Research.

Authors:  Nara Liessi; Nicoletta Pedemonte; Andrea Armirotti; Clarissa Braccia
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.